Kuwait Approves Pfizer-BioNTech, Bahrain Registers Sinopharm

Photographer: hang Yuwei/Xinhua/Getty Images

Lock
This article is for subscribers only.

Bahrain has approved Chinese-made Sinopharm Group Co.’s vaccine for widespread usage on Sunday while neighboring Kuwait authorized the use of Pfizer Inc. and BioNTech SE’s vaccine.

Bahrain had previously authorized the emergency use of the vaccine, which was provided to frontline workers in contact with coronavirus patients. The vaccine has already been administered to hundreds of thousands of people under emergency authorization in China, but it’s yet to receive public use approval from any drug regulators.